Unlike past pharmaceutical litigation, lawsuits over allegations that women’s use of Zoloft during their pregnancies caused birth defects in their children are coalescing in federal court instead of state courts across the country, a defense attorney for drugmaker Pfizer said during a multidistrict litigation court hearing Monday.
Defense counsel Mark S. Cheffo of Skadden, Arps, Slate, Meagher & Flom in New York told the panel that the number of state court cases is shrinking.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
